Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Cannon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pediatrics|February 25, 2016
Preschool Assessment of Preterm Infants Treated With Darbepoetin and ErythropoietinRobin K Ohls, Daniel C Cannon, John Phillips, et al.
Pediatric Research|May 30, 2017
Neuroimaging in former preterm children who received erythropoiesis stimulating agentsJohn Phillips, Ronald A Yeo, Arvind Caprihan, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 29, 2021
Effect of blood transfusions on cognitive development in very low birth weight infantsPriya Shah, Daniel C Cannon, Jean R Lowe, et al.
Bioinformatics (Oxford, England)|April 12, 2017
TIN-X: target importance and novelty explorerDaniel C Cannon, Jeremy J Yang, Stephen L Mathias, et al.
Psychoneuroendocrinology|November 21, 2019
Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorderAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
JMIR Mental Health|March 10, 2021
Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness StudyAnastasiya Nestsiarovich, Praveen Kumar, Nicolas Raymond Lauve, et al.
Journal of Affective Disorders|April 16, 2019
Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacyAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
Pediatrics|May 14, 2014
Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placeboRobin K Ohls, Beena D Kamath-Rayne, Robert D Christensen, et al.
Peerj|July 1, 2024
TIN-X version 3: update with expanded dataset and modernized architecture for enhanced illumination of understudied targetsVincent T Metzger, Daniel C Cannon, Jeremy J Yang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pediatrics|February 25, 2016
Preschool Assessment of Preterm Infants Treated With Darbepoetin and ErythropoietinRobin K Ohls, Daniel C Cannon, John Phillips, et al.
Pediatric Research|May 30, 2017
Neuroimaging in former preterm children who received erythropoiesis stimulating agentsJohn Phillips, Ronald A Yeo, Arvind Caprihan, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 29, 2021
Effect of blood transfusions on cognitive development in very low birth weight infantsPriya Shah, Daniel C Cannon, Jean R Lowe, et al.
Bioinformatics (Oxford, England)|April 12, 2017
TIN-X: target importance and novelty explorerDaniel C Cannon, Jeremy J Yang, Stephen L Mathias, et al.
Psychoneuroendocrinology|November 21, 2019
Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorderAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
JMIR Mental Health|March 10, 2021
Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness StudyAnastasiya Nestsiarovich, Praveen Kumar, Nicolas Raymond Lauve, et al.
Journal of Affective Disorders|April 16, 2019
Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacyAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
Pediatrics|May 14, 2014
Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placeboRobin K Ohls, Beena D Kamath-Rayne, Robert D Christensen, et al.
Peerj|July 1, 2024
TIN-X version 3: update with expanded dataset and modernized architecture for enhanced illumination of understudied targetsVincent T Metzger, Daniel C Cannon, Jeremy J Yang, et al.
Pageof 1